ENHANCING PREDICTION OF MODERATE FIBROSIS OR HIGHER IN MASLD PATIENTS FOR RESMETIROM TREATMENT VIA MACHINE LEARNING

被引：0

作者：

Dunn, Winston ^{[1
]}

Alkhouri, Naim ^{[2
]}

Yip, Terry Cheuk-Fung ^{[3
]}

Castera, Laurent ^{[4
]}

Takawy, Marina ^{[5
]}

Adams, Leon ^{[6
]}

Verma, Nipun ^{[7
]}

Arab, Juan Pablo ^{[8
]}

Jafri, Syed-Mohammed ^{[9
]}

Zhong, Bihui ^{[10
]}

Dubourg, Julie ^{[11
]}

Chen, Vincent ^{[3
,12
]}

Singal, Ashwani ^{[13
]}

Antonio Diaz, Luis ^{[14
]}

Dunn, Nicholas ^{[1
]}

Nadeem, Rida ^{[2
]}

Wong, Vincent

Abdelmalek, Manal ^{[15
]}

Wang, Zhengyi ^{[6
]}

Duseja, Ajay ^{[16
]}

Almahanna, Yousef ^{[17
]}

Omeish, Haya ^{[18
]}

Ye, Junzhao ^{[19
]}

Harrison, Stephen ^{[20
]}

Arrese, Marco ^{[14
]}

Robert, Sage ^{[1
]}

Wong, Grace Lai-Hung ^{[3
]}

Bajunayd, Bajunayd ^{[17
,21
]}

Shao, Congxiang ^{[19
]}

机构：

[1] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA

[2] Arizona Liver Hlth, Phoenix, AZ USA

[3] Chinese Univ Hong Kong, Hong Kong, Peoples R China

[4] Hop Beaujon, Clichy, France

[5] Mayo Clin, Rochester, MN USA

[6] Univ Western Australia, Nedlands, WA, Australia

[7] Postgrad Inst Med Educat, Chandigarh, India

[8] Univ Western Ontario, London, ON, Canada

[9] Henry Ford Hlth Syst, Detroit, MI USA

[10] First Affiliated Hosp, Guangzhou, Peoples R China

[11] Summit Clin Res, San Antonio, TX USA

[12] Univ Michigan, Med Ctr, Ann Arbor, MI 48109 USA

[13] Univ Louisville, Louisville, KY 40292 USA

[14] Pontificia Univ Catolica Chile, Santiago, Chile

[15] Mayo Clin Rochester, Rochester, MN USA

[16] Postgrad Inst Med Educ & Res, Chandigarh, India

[17] Western Univ, London, ON, Canada

[18] Henry Ford Hlth, Detroit, MI USA

[19] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Peoples R China

[20] Univ Oxford, Oxford, England

[21] London Hlth Scien, London, ON, Canada

来源：

HEPATOLOGY | 2024年 / 80卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

743

引用

页码：S553 / S555

页数：3

共 50 条

[1] Enhancing prediction of moderate fibrosis in MASLD patients for Resmetirom treatment via machine learning
Dunn, Winston
Alkhouri, Naim
Yip, Terry Cheuk-Fung
Castera, Laurent
Takawy, Marina
Adams, Leon
Verma, Nipun
Arab, Juan Pablo
Jafri, Syed-Mohammed
Zhong, Bihui
Dubourg, Julie
Chen, Vincent
Singal, Ashwani K.
Antonio Diaz, Luis
Dunn, Nicholas
Nadeem, Rida
Wong, Vincent Wai-Sun
Abdelmalek, Manal F.
Wang, Zhengyi
Duseja, Ajay Kumar
Almahanna, Yousef
Bajunayd, Amani
Omeish, Haya A.
Ye, Junzhao
Harrison, Stephen A.
Wong, Grace Lai-Hung
Arrese, Marco
Robert, Sage
Shao, Congxiang
JOURNAL OF HEPATOLOGY, 2024, 80 : S84 - S84
[2] ENHANCING TRADITIONAL FIBROSIS PREDICTION MODELS WITH MACHINE LEARNING IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
Kim, David
Qureshi, Imran
Ismail, Mohamed
Abboud, Yazan
Pyrsopoulos, Nikolaos
Kim, Hyunseok
Hajifathalian, Kaveh
Al-Khazraji, Ahmed
HEPATOLOGY, 2024, 80 : S587 - S588
[3] Enhancing synthesis prediction via machine learning
Schoen, J. C.
NATURE COMPUTATIONAL SCIENCE, 2025, 5 (02): : 95 - 96
[4] IMPACT OF DELAYED TREATMENT INITIATION WITH RESMETIROM IN PATIENTS WITH NONCIRRHOTIC NONALCOHOLIC STEATOHEPATITIS (NASH) WITH MODERATE TO ADVANCED FIBROSIS
Ansaripour, A.
Kim, Y.
Montero, M. Gomez
Hosmane, S.
VALUE IN HEALTH, 2024, 27 (12)
[5] FDA approves Resmetirom: groundbreaking treatment for NASH liver scarring in moderate to advanced fibrosis
Waheed, Aiman
Gul, Muhammad H.
Shabbir, Muhammad U. B.
Raja, Hafsa A. A.
Wardak, Abdul B.
Hussaini, Helai
Shah, Yash
ANNALS OF MEDICINE AND SURGERY, 2025, 87 (03): : 1088 - 1091
[6] A Markov model unveiling the impact of Resmetirom on the natural history of MASLD patients with baseline significant or severe liver fibrosis
Pennisi, Grazia
Di Maria, Gabriele
Enea, Marco
Vaccaro, Marco
Ciccioli, Carlo
Celsa, Ciro
Infantino, Giuseppe
Tulone, Adele
Di Marco, Vito
Camma, Calogero
Petta, Salvatore
JOURNAL OF HEPATOLOGY, 2024, 80 : S609 - S609
[7] A Markov model unveiling the impact of Resmetirom on the natural history of MASLD patients with baseline significant or severe liver fibrosis
Pennisi, G.
Di Maria, G.
Celsa, C.
Enea, M.
Vaccaro, M.
Ciccioli, C.
Infantino, G.
Tulone, A.
Di Marco, V.
Camma, C.
Petta, S.
DIGESTIVE AND LIVER DISEASE, 2024, 56 : S14 - S14
[8] MACHINE LEARNING ALGORITHMS FOR PREDICTION OF NASH AND ADVANCED FIBROSIS IN NAFLD PATIENTS
Kosick, Heather M.
McIntosh, Chris
Fakhriyehasl, Mina
Bera, Chinmay
Adeyi, Oyedele
Jhaveri, Kartik
Patel, Keyur
GASTROENTEROLOGY, 2022, 162 (07) : S1293 - S1294
[9] Treatment prediction with machine learning in prostate cancer patients
Alatas, Emre
Kokkulunk, Handan Tanyildizi
Tanyildizi, Hilal
Alcin, Goksel
COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING, 2025, 28 (04) : 572 - 580
[10] FOLFOX treatment response prediction in metastatic or recurrent colorectal cancer patients via machine learning algorithms
Lu, Wei
Fu, Dongliang
Kong, Xiangxing
Huang, Zhiheng
Hwang, Maxwell
Zhu, Yingshuang
Chen, Liubo
Jiang, Kai
Li, Xinlin
Wu, Yihua
Li, Jun
Yuan, Ying
Ding, Kefeng
CANCER MEDICINE, 2020, 9 (04): : 1419 - 1429

← 1 2 3 4 5 →